Anu Wartiovaara (née Suomalainen; born 1966) is a Finnish neuroscience and biomedical researcher, holding the Sigrid Jusélius Professorship of clinical molecular medicine at the University of Helsinki, specialising in mitochondrial disorders.[2]

Professor
Anu Wartiovaara
Born
Anu Elina Suomalainen

1966 (age 57–58)[1]
Alma materUniversity of Helsinki
Scientific career
InstitutionsUniversity of Helsinki
ThesisMutations of mitochondrial DNA in human disease (1993)

She has also been appointed as an Academy Professor of the Research Council of Finland since 2017.[2]

In 2007, Wartiovaara was elected as a member of the Finnish Academy of Science and Letters.[3]

In 2013, she was elected as member of the European Molecular Biology Organization EMBO.[4]

In 2021, the Finnish Medical Society Duodecim [fi] awarded Wartiovaara the Matti Äyräpää Prize for her work on mitochondrial diseases.[5]

In 2022, she was elected Member of the Academia Europaea.[6]

She gained an MD and PhD from the University of Helsinki, with postdoctoral research at the National Public Health Institute of Finland and McGill University of Canada.[7]

Some of Wartiovaara's publications have appeared under her maiden name Suomalainen, or Suomalainen-Wartiovaara.[2]

References

edit
  1. ^ "Kotimaiset jäsenet" (in Finnish). Finnish Academy of Science and Letters. Archived from the original on 12 June 2018.
  2. ^ a b c "Akatemiaprofessorit" (in Finnish). University of Helsinki. Retrieved 29 October 2023.
  3. ^ "Varsinaiset jäsenet" [Full members] (in Finnish). Finnish Academy of Science and Letters. Retrieved 29 October 2023.
  4. ^ "EMBO announces new members for 2013". EMBO. Archived from the original on 11 May 2019. Retrieved 29 October 2023.
  5. ^ "Matti Äyräpään palkinto mitokondriotautien tutkija Anu Wartiovaaralle" (in Finnish). Duodecim. Retrieved 29 October 2023.
  6. ^ "Anu Suomalainen Wartiovaara". Academia Europaea. Retrieved 29 October 2023.
  7. ^ "Anu Suomalainen Wartiovaara". The Lancet Neurology. Retrieved 29 October 2023.
edit